In this week's addition, the FDA approval of a transdermal patch to treat Alzheimer’s-related dementia; the link between daily napping among older adults and an increased risk for Alzheimer’s disease; an oral treatment for Parkinson’s demonstrated positive phase 2 results; and more.
Read the full coverage here:
FDA approves transdermal patch to treat Alzheimer’s-related dementia
Daily napping among older adults linked to a 40% higher risk for Alzheimer’s disease
Oral treatment for Parkinson’s shows positive phase 2 results
Sleep academy warns lawmakers about health risks of permanent daylight saving time
AAN: Medication, exercise more beneficial than stent in preventing stroke
References:
Li P, et al. Alzheimers Dement. 2022;doi:10.1002/alz.12636.
Turan TN, et al. Neurology. 2022;doi:10.1212/WNL.0000000000200030.
